Pierce Boyne, PT, DPT, PhD, NCS; Sandra A. Billinger, PT, PhD; Darcy S. Reisman, PT, PhD; et al.
free access
has audio
JAMA Neurol. 2023;80(4):342-351. doi:10.1001/jamaneurol.2023.0033
This randomized clinical trial compares vigorous vs moderate walking exercise to assess the optimal intensity and training duration to maximize improvement in walking capacity among stroke survivors with walking limitations.
-
Podcast:
Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic Stroke
Yenee Soh, ScD; Rachel A. Whitmer, PhD; Elizabeth Rose Mayeda, PhD, MPH; et al.
free access
JAMA Neurol. 2023;80(4):352-359. doi:10.1001/jamaneurol.2022.5337
This cohort study evaluated the association between state-level educational quality during childhood and incident dementia in adults aged 65 years or older.
Niklas Mattsson-Carlgren, MD, PhD; Gemma Salvadó, PhD; Nicholas J. Ashton, PhD; et al.
open access
JAMA Neurol. 2023;80(4):360-369. doi:10.1001/jamaneurol.2022.5272
This prognostic study uses data from the Swedish BioFINDER-1 and Wisconsin Registry for Alzheimer Prevention longitudinal cohort studies to evaluate whether combinations of different plasma biomarkers can predict cognitive decline in cognitively unimpaired individuals with 尾-amyloid positivity.
Francine Grodstein, ScD; Sue E. Leurgans, PhD; Ana W. Capuano, PhD; et al.
free access
JAMA Neurol. 2023;80(4):370-376. doi:10.1001/jamaneurol.2022.5416
This cohort study characterizes trends in pathways underlying dementia by examining prevalence of postmortem neuropathologies in birth cohorts across 25 years.
Adit Friedberg, MD; Lorenzo Pasquini, PhD; Ryan Diggs, BA; et al.
open access
JAMA Neurol. 2023;80(4):377-387. doi:10.1001/jamaneurol.2023.0001
This case-control study assesses the anatomical and physiological underpinnings of visual artistic creativity in individuals with frontotemporal dementia.
Nicholas J. Ashton, PhD; Marion Moseby-Knappe, PhD; Andrea L. Benedet, PhD; et al.
open access
JAMA Neurol. 2023;80(4):388-396. doi:10.1001/jamaneurol.2023.0050
This case-control study evaluates the potential role of blood phosphorylated tau and amyloid-尾 peptides in neurological prognostication following cardiac arrest.